Cahaba Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$224K Sell
637
-68
-10% -$24.2K 0.02% 142
2025
Q4
$231K Sell
705
-11
-2% -$3.49K 0.02% 139
2025
Q3
$202K Sell
716
-140
-16% -$40.6K 0.01% 151
2025
Q2
$239K Sell
856
-131
-13% -$37.1K 0.02% 138
2025
Q1
$307K Buy
987
+10
+1% +$2.95K 0.03% 112
2024
Q4
$255K Buy
977
+1
+0.1% +$297 0.02% 129
2024
Q3
$315K Hold
976
0.03% 119
2024
Q2
$305K Sell
976
-87
-8% -$25.6K 0.03% 115
2024
Q1
$302K Hold
1,063
0.03% 114
2023
Q4
$306K Sell
1,063
-114
-10% -$31.1K 0.03% 104
2023
Q3
$316K Sell
1,177
-627
-35% -$156K 0.03% 104
2023
Q2
$401K Sell
1,804
-107
-6% -$24.8K 0.04% 89
2023
Q1
$462K Sell
1,911
-20
-1% -$4.91K 0.05% 86
2022
Q4
$507K Sell
1,931
-56
-3% -$15K 0.06% 77
2022
Q3
$447K Buy
1,987
+14
+0.7% +$3.39K 0.06% 80
2022
Q2
$480K Sell
1,973
-160
-8% -$39.2K 0.07% 75
2022
Q1
$497K Sell
2,133
-227
-10% -$52.2K 0.07% 83
2021
Q4
$531K Buy
2,360
+435
+23% +$91.8K 0.07% 79
2021
Q3
$409K Buy
+1,925
New +$443K 0.06% 91

Other funds holding AMGN

Cahaba Wealth Management's AMGN Position: Q1 2026 in Review

Cahaba Wealth Management reduced its Amgen (AMGN) stake by 9.6% in Q1 2026, selling an estimated $24.2K and leaving 637 shares worth $224K. The position accounts for 0.02% of the portfolio, ranked #142.

Cahaba Wealth Management first reported a position in AMGN in Q3 2021 and has held it in 19 quarters since. The position peaked at $531K in Q4 2021. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Cahaba Wealth Management held 637 shares of Amgen worth $224K as of Q1 2026.
  • Cahaba Wealth Management sold 68 Amgen shares in Q1 2026, an estimated $24.2K.
  • Amgen made up 0.02% of Cahaba Wealth Management's portfolio in Q1 2026, its #142 holding.
  • Cahaba Wealth Management first reported a position in Amgen in Q3 2021 and has held it in 19 quarters since.
  • Cahaba Wealth Management's Amgen position peaked at $531K in Q4 2021.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Cahaba Wealth Management's 13F filing for Q1 2026, filed 29 Apr 2026.